WASHINGTON - U.S. personnel working at an Army facility in Utah appeared to follow correctly all the outlined procedures to inactivate anthrax before they mistakenly shipped off live samples of the deadly bacteria, the Army's top general said on Thursday. | Video
- The U.S. Food and Drug Administration has asked manufacturers of dermal fillers to update their labeling to reflect the possible risk of serious injuries caused by unintentional injection of the fillers into the blood vessels in the face.
WASHINGTON - The U.S. Food and Drug Administration on Thursday approved the first drug to treat a rare, progressive lung disease that mainly affects women of childbearing age.
(Reuters Health) - People with heart conditions may benefit from using indoor air purifiers, suggests a small study from China.
- Heron Therapeutics Inc said its experimental drug for treating chemotherapy-induced nausea and vomiting (CINV) met its main goal in a late-stage trial.
- A Delaware jury on Thursday ordered Boston Scientific to pay $100 million to a woman who said she was injured by transvaginal mesh, a device that is the subject of more than 25,000 lawsuits against the company.
(Reuters Health) - - People who have better aerobic fitness in middle age may ward off decreases in brain volume later in life, potentially preserving memory and other functions, a U.S. study suggests.
- A U.S. district court has ruled that Amarin Corp's fish oil pill, Vascepa, is eligible for five years of marketing exclusivity, setting aside a U.S. Food and Drug administration decision.
SEOUL - South Korea's tally of patients of Middle East Respiratory Syndrome (MERS) rose to seven on Thursday, with authorities saying one suspected victim skipped out of voluntary home quarantine to take a trip to China.
PARIS - Ivory Coast has confirmed an outbreak of highly pathogenic H5N1 bird flu last month among backyard birds in the central town of Bouake, the World Organisation for Animal Health (OIE) said on Thursday.